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CHANGES OF THE ELECTROPHORETIC PATTERNS OF THE SERA OF
PSORIATICS UNDER VARIOUS FORMS OF THERAPY*
FREDERICK KALZ, M.D.,t J. H. QUASTEL, PH.D.,t PAUL TELNER, M.D.,t
A. SCHAFER, M. Sc.t AND W. MAcINTYRE, B. Sc.t
A few years ago we described some abnormali-
ties in the plasma protein pattern of psoriatie
patients as determined by paper chromatography;
we could not, however, explain the meaning of
the observed changes (1). Lever (2), who was the
first to report on protein fractionation in psoria-
sis, used free boundary electrophoresis and found
normal patterns in four patients with uncompli-
cated psoriasis, while psoriatic erythrodermas
showed some abnormalities. Bolgert and asso-
ciates (3) found an elevation in the beta zone in
seven out of fourteen plasmas of psoriaties ex-
amined by means of paper electrophoresis, while
Menegheni et al (4), also using separation on
paper, noted an increase in lipoproteins in
psoriatics. Schuster, Walker, A. Lea, Block and
Curtis (10) and Walker, A. Lea, Cornish and
Block (11) reported minor changes in lipids, pro-
teins and lipoproteins in psoriatics but attributed
these abnormalities to a concomitant latent or
overt atherosclerosis.
The present study deals with the electro-
phoretic patterns of sera of psoriaties as compared
with those of normal controls and particularly
with the changes of the beta-lipoproteins that
occur in response to the administration of ultra-
violet irradiation and to that of a chelating
agent the calcium di-sodium salt of ethylene
diamine tetra-acetie acid (EDTA) t.
MATERIALS AND METHODS
1. The sera of 14 psoriatic patients, 7 men and
seven women, from 22 to 62 years of age were
examined by free boundary eleetrophoresis and
the mean values compared with those of normal
controls. (Standard control series of the labora-
tory, mean values pooled of men and women.)
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2. Paper electrophoresis was performed in pre-
liminary experiments on the sera of nine psoriaties
during the year 1955*. Protein and lipid stains
were used (5, 6). The sera of the patients were
examined at various times and tested at different
stages of the disease.
3. The sera of 16 patients with uncomplicated
psoriasis were tested in the same manner during
the years 1956 and 1957 (5). For the demonstra-
tion of lipids the method of Swahn (6) was
adopted without any modification other than
that the finished strips were rinsed in distilled
water. The results were read on an Eel scanner
and the stained area was measured by a com-
pensating polar planimeter.
Six of these patients were treated by daily
total exposure to ultraviolet radiation for ten
days. At least one blood specimen was taken be-
fore therapy was started, one at the end of the
ten days course and one ten days after termina-
tion of therapy. Two of these six patients were
tested during a second course of ultraviolet
therapy in an identical manner. Four normal
volunteers served as controls for this form of
therapy; one of them had a second course of U.V.
treatment.
4. Five patients received a daily dose of three
grams of EDTA orally for 10 days. The sera were
examined before and at the end of the ten days
treatment. The effect of smaller doses and the
results of retreatment were also investigated.
5. The sera of 11 normal subjects were used as
controls.
6. A total of 59 blood specimen was examined.
36 of these blood samples were also tested in a
different laboratory for the purpose of further
controlt; the technic of Sehon et al (7) for pro-
tein fractionation being used in these eases.
out in the laboratories of the University Clinic of
the Royal Victoria Hospital, through the courtesy
of Dr. B. Rose, under the supervision of Dr. A.
Sehon.
* The investigations during 1955 were partially
supported by a grant from the Ciba Co. Ltd.
t Dept. of Allergy, Royal Victoria Hospital.
Dr. Bram Rose.
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Our preliminary investigations had shown that
paper eleetrophoresis of lipoproteins was not an
exact quantitative procedure, and that deter-
minations made on different days on the same
serum showed variations up to 15%. For this
reason, all sera obtained during the observation,
treatment and follow up periods of any given
patient were stored at —20°C and examined on
the same day. The specimens were numbered 1,
2, and 3, respectively. Specimens 1 and 2, 1 and
3, and 2 and 3 were examined as pairs. In this
way, the reproducibility was increased and the
range of variations was less than 4%.
Each test was carried out in triplicate and, in
all, over 500 determinations were made.
7. The total proteins were determined for each
specimen by the biuret method and read on a
Beckman spectro-photometer. Each specimen
was also examined by the Kjeldahl method.
8. Total cholesterols and lipid phosphorus
were determined on 37 specimens*, including all
of those who underwent EDTA therapy.
9. Several blood specimens were taken during
the pre-treatment period from a number of
patients in order to establish a base line value.
Only two patients were under a rigid dietary con-
trol because this necessitated an additional hos-
pitalization of ten days. These two patients were
put on a controlled low fat diet and three blood
samples were taken at an interval of three days
before commencement of therapy.
Eight patients were hospitalized during the
test periods, the others were ambulant patients.
There are a number of shortcomings inherent
in some of the procedures. Ultraviolet therapy is
not suitable for quantitation as the response of
the skin to a given dose is an individual and
variable factor. The attempt was made to obtain
a full erythema with each daily exposure and the
physical factors (distance and irradiation time)
were arbitrarily determined for each case from
day to day. The psoriasis patients received addi-
tional tar applications, which for obvious reasons
were omitted in the control subjects. In two cases
follow up tests could not be done because the
patient was not available.
We emphasize, therefore, the changes occurring
in each patient during therapy and less stress is
placed upon the variations observed among
different patients.
* Biochemical laboratory, Royal Victoria Hos-
pital, Courtesy Dr. K. MacKenzie.
% of Total
Proteins
Standard
Deviation
Free Boundary Electrophore-
sis:
Normals (64) 12.95
Psoriatics (14) 16.60
Paper Eleclrophoresis:
Normals (11) 12.8
Psoriatics (16) 14.1
10. All tabulated results have been subjected
to statistical analysis.
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The scra of the 14 patients, tested by the
Tiselius method, gave beta globulin values
whose range was significantly higher than that
obtained with normal sera (see Table I).
This fact is reflected in a statistically signifi-
cant difference between the mean values of the
two groups (P0 < 001). A Comparable differ-
ence was also found between the mean values
obtained by paper clectrophoresis (P0 < 002).
Estimations of the beta lipoproteins of the
sera of psoriatics, as compared with those of
normal controls, showed similar changes. Statis-
tical analysis of the results indicated, however, a
rather wide range of variation, so that a larger
series and more controls will require examina-
tion to measure the differences exactly. "The
elevation of the beta globulins was found in the
sera of 6 of the 14 patients tested by the Tiselius
method; no overt cases of atherosclerosis were
found but presence of latent changes could not be
ruled out."
The mean values of the lipoproteins of six
psoriasis patients and four control subjects are
given in Fig. 1. Ultraviolet light caused a sharp
decrease of these values in each individual of
both groups, which lasted for considerable periods
of time. The decrease was statistically significant
(P0 <002.)
Altschul (8) reported a decrease of the serum
cholesterol, after ultraviolet irradiation, in a
group of patients with higher initial values of
serum cholesterol while a group with normal
cholesterol values showed little changes under
the same conditions. Our results (Fig. 1) demon-
strate a similar, but more marked, decrease of
TABLE I
Mean Values of Bet a Globulin
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the beta lipoproteins which was noted in all cases
with either high or normal initial values.
EDTA given orally in a dosage of 3 grams
daily for ten days resulted in a marked decrease
of the beta-lipoproteins in every case tested
(P0 < 002), see Fig. 2. This decrease continued
during further therapy but to a lesser extent. The
pretreatment values in this group were somewhat
lower than the average for psoriatics because two
patients who had previous ultraviolet therapy
have been included.
The patients were retreated with the same dose
of EDTA after a ten days rest period. As shown
in Fig. 3, retreatment results in an insignificant
further decrease of the beta lipoproteins.
The photograph of the first three strips in Fig.
4 demonstrates the effect of controlled low fat diet
over a ten day period. Blc 1 was taken at 3 day
intervals. A reduction in r Litral fat and particu-
larly in the alpha lipopri ems is evident. The
beta lipoprotein zone shows only insignificant
changes. The fourth strip shows the effect of ten
days therapy with EDTA, resulting in a marked
decrease of the beta lipoproteins. The lipid phos-
phorus decreased during the diet period; the
cholesterol value showed little change. EDTA
therapy resulted in a marked decrease of both
lipid constituents in the sera tested.
The correlation between the fall in serum
cholesterol and in serum beta lipoproteins is
demonstrated in the curves shown in Fig. 5.
These relate to two psoriatics; case No. I. illus-
trates the observation that initially low cho-
lesterol values change but little under EDTA
therapy, while the lipoproteins diminish in all
cases tested. Schroder (9) reported the decrease
of serum cholesterol after oral EDTA administra-
tion in conjunction with a diet high in unsatu-
rated, and low in saturated fatty acids. We can
confirm his findings with regard to the effect of
EDTA on serum cholesterol where the initial
value is high. and can add the observation of an
even more marked decrease of the beta lipo-
proteins with this form of therapy. This decrease
was particularly striking in a case of very high
blood lipids,* see Table II. The presence of high
beta globulins in this case is consistent with the
view that a considerable part of the serum lipids
may move with the globulin fraction. This may
explain to some extent the findings of elevated
beta globulins in the majority of psoriatics as it
is known that lipid fractions tend to be elevated
in some psoriatics. It may well be that this ab-
normality was partly responsible, for the changes
observed in the sera of psoriatics examined by
means of chromatography.
* This patient, who suffered from a xanthoma
tuberosum as well as from psoriasis, has not been
included in the above tabulations except Table 2.
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diet of our ambulant patients. l3oth ultraviolet
and EDTA therapy reduce the value of the serum
lipid phosphorus.
An attempt was made to study the effect of
external application of a tar ointment in 3 pa-
tients. One patient was investigated at regular
intervals for more than two years and multiple
tests were carried out at these intervals. The
results were inconclusive since spontaneous remis-
sions and exacerbations of the psoriasis inter-
vened. It was our impression that the beta lipo-
proteins increased during periods of activity of
the disease and decreased with its remissions.
The alpha 2 lipoprotcins tend to disappear
temporarily during acute exacerbations of the
psoriasis.
SUMMARY
1. Estimations have been made, in about 500
samples on 78 sera from psoriatic patients and
from normal control subjects, of the contents of
(mgm %) beta globulins and of beta lipoproteins using
electrophoretic methods.
2. Values of beta globulins are 20—30% higher
in the sera of patients with psoriasis than in
20 those of healthy control subjects. Values of sera
beta lipoproteins tend to behave similarly.
Whether this is an inherent feature of some pso-
riatic patients, or due to a fortuitous association
with a latent atherosclerosis, cannot be decided.
3. Ultraviolet irradiation reduces the sera
beta lipoproteins significantly, and rapidly, iii
psoriatics as well as in normal control subjects.
4. Oral EDTA therapy results in a similar
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TABLE II
Total
Protein
(gm %)
8.65
7.9
Beta
Glob.
(% of
TP)
34.1
30.7
Beta
Lipo.
(mm2)
969
400
Total
Choles.
(mgm %)
558 23Before Ther-
apy
After 15 days
of E.D.T.
A. (1.5gm.
daily)
366
Examination of the serum lipid phosphorus
have given inconsistent results. Fat intake modi-
fies the serum content of the Phospholipid and
we have been unable to control satisfactorily the
;#? lt' "o
S 0
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rapid decrease of the beta lipoproteins in the
psoriatic patient.
Acknowledgment: We are much indebted to
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DISCUSSION
DR. FREDERICK REISS (New York, N. Y.): Dr.
Kalz's paper is a very challenging one. As all in-
vestigations which deal with the metabolic
problem of psoriasis demonstrate, it is very diffi-
cult to compare findings of investigators if one
does not follow exactly the same method.
We happen to have become interested in the
same problem at Bellevue Hospital and we have
completed the investigation of 14 cases of psori-
asis. However, we have not been able to do in-
vestigations of lipoproteins but only of alpha,
beta and gamma globulins. In this line we have
not seen very much change in the beta globulins.
Among the 14 patients, one case showed a de-
crease in alpha globulin, 3 patients showed a
slight increase in gamma globulins. We also
have been interested in what the effect beta
sitosterol has on the cholesterol level and the
course of psoriasis. The result was rather disap-
pointing in so far as that beta sitosterol showed
erratic changes of cholesterol levels although it
can be stated that in most instances it depresses
cholesterol as long as sitosterol is given; particu-
larly if it is given during meals. It is also of inter-
est to note that the clinical improvement of
psoriasis was not in line with the increase or de-
crease of cholesterol levels. In other words, when
the cholesterol level showed a decrease the
process was often worsening and on the con-
trary, when the cholesterol level rose, psoriasis im-
proved.
I would like to ask Dr. Kalz, what is the rela-
tionship between improvement of the psoriatic
process and the decrease of beta lipoprotein with
chelating agent? What dose is given? Were any
changes observed in the electrolyte balance?
DR. WALTER F. LEVER (Boston, Mass.): I en-
joyed hearing Dr. Kalz's paper. One can divide
his paper into two parts, the one part dealing
with the lipoprotein levels in normal individuals
and in patients with psoriasis and the other part
dealing with therapeutic results.
In the first part Dr. Kalz tried to establish
the difference between normal individuals and
patients with psoriasis as far as their quantity of
lipoproteins is concerned. I do not know whether
the differences are valid until I have had an op-
portunity to study the data in detail. Age and
sex have to be taken into consideration because
the amount of beta lipoprotein is known to in-
crease with age and is generally higher in males
than in females.
The second part dealt with the lipid-lowering
effects of the chelating agent EDTA and of ultra-
violet light. Dr. Kalz and his coworkers found
approximately the same lipid-decreasing effects in
normals and in psoriatics. Therefore it is not
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possible to assume without further proof a rela-
tionship between the deerease in lipids and the
therapeutic effects that were obtained in psoriasis
with the ultraviolet light therapy or EDTA. Dr.
Kalz and his coworkers deserve considerable
credit for the vast amount of work they have
done on this problem and I hope that they will
continue it.
Da. FREDERICK KALZ (in closing): I wish to
thank the discussers for their remarks. In answer
to Dr. Reiss, we did not observe any decrease of
the beta globulins after therapy with either ultra-
violet or EDTA, only the beta lipoproteins de-
creased. With regard to the dosage, three grams
of EDTA were given and the calcium salt of this
compound was used, which is not supposed to
alter the serum calcium content.
In answer to Dr. Lever, the electrophoretic
changes observed after ultraviolet were the same
in normals as in psoriatics. We shared his doubts
about differences in the amount of beta globulines
between normals and psoriatics. Because of our
doubts examinations were done in three labora-
tories, using three different methods. Our results
were checked in Dr. B. Rose's laboratory, using
free boundary electrophoresis and a third batch
of cases—I did not have the time to mention
it—were done in the Allergy laboratories of the
Royal Victoria Hospital, using a different technic
of paper electrophoresis. With all three methods
a statistically significant difference was noted.
